Identification of mesenteric lymph node (MLN) bacteria showed that indigenous streptomycin-sensitive Escherichia coli could be recovered from MLN at least 48 h after this organism had been essentially eliminated from the cecal flora by antibiotics and replaced with exogenous streptomycin-resistant E. coli JK. Additional experiments with antibiotic-treated rats also showed that indigenous streptomycin-sensitive E. coli could be recovered from the MLN 4 days after elimination of this organism from the cecal flora. These findings suggest that the time of bacterial translocation to MLN may be kinetically different from the time of recovery of bacteria from MLN and that the MLN may be a focus of infection with intestinal bacteria.
Identification of mesenteric lymph node (MLN) bacteria showed that indigenous streptomycin-sensitive Escherichia coli could be recovered from MLN at least 48 h after this organism had been essentially eliminated from the cecal flora by antibiotics and replaced with exogenous streptomycin-resistant E. coli JK. Additional experiments with antibiotic-treated rats also showed that indigenous streptomycin-sensitive E. coli could be recovered from the MLN 4 days after elimination of this organism from the cecal flora. These findings suggest that the time of bacterial translocation to MLN may be kinetically different from the time of recovery of bacteria from MLN and that the MLN may be a focus of infection with intestinal bacteria.
Studies have shown that intestinal bacteria can translocate into mesenteric lymph nodes (MLN), but it is not known if these bacteria can survive within MLN. Several reports have suggested that MLN can be an initial site of invasion by intestinal bacteria prior to bacterial dissemination into other tissues such as the liver, spleen, and kidneys (1, 3, 5, 9, 11, 15, 17) . Thus, the ability of an organism to survive within MLN may be an important factor contributing to the ability of the organism to cause systemic disease.
Our laboratory has been engaged in studies designed to clarify the route(s) and mechanism(s) whereby intestinal bacteria leave the intestinal lumen and cause systemic disease. It has been documented that from 0 to 20% of untreated laboratory rats and mice typically have viable translocating intestinal bacteria that can be recovered from MLN (1, 2, 7, 9, 17) . We recently noted that our supply of locally purchased laboratory rats had a high rate of spontaneous translocation of indigenous streptomycin-sensitive Escherichia coli. During the present experiments, this organism was consistently recovered from the MLN of nearly all untreated rats. This situation provided a unique animal model that could be used to assess the ability of E. coli to survive within MLN. The results of this study indicated that translocating intestinal E. coli could remain viable within MLN for several days.
Separate groups of 20 male, 200-g Sprague-Dawley rats (Bio-Lab Corp., St. Paul, Minn.) were given drinking water supplemented with either 2 mg of streptomycin sulfate (Sigma Chemical Co., St. Louis, Mo.) per ml or 4 mg of neomycin sulfate (The Upjohn Co., Kalamazoo, Mich.) per ml. Control rats were given unsupplemented drinking water. After 3 days of drug therapy, 10 rats per group were sacrificed, and cecal and MLN bacteria were identified and quantitated as described below. The remaining 10 rats in each group were orally inoculated with streptomycinresistant E. coli JK, a strain that had been previously isolated from the cecal contents of this animal colony approximately 1 year prior to the present experiments. Stock cultures of this strain had been maintained at -20°C in brain * Corresponding author.
heart infusion broth (Difco Laboratories, Detroit, Mich.) supplemented with 10% glycerol. A feeding needle was used to inoculate each rat with 0.5 ml of sterile saline containing approximately 1010 saline-washed E. coli JK from an overnight brain heart infusion broth culture. Rats were sacrificed 48 h later, and cecal and MLN bacteria were again identified and quantitated. This experiment was performed twice within a 2-month period.
Each rat was killed by CO2 asphyxiation, and the MLN was excised prior to excision of the cecum. Tissues were processed aseptically. Each MLN was homogenized in 2 ml of phosphate-buffered saline with 0.01% gelatin (4 Table 1 presents the results of bacterial cultures of the cecal and MLN tissues from the various rat groups before and after oral inoculation with streptomycin-resistant E. coli JK. In all animals from which translocating bacteria were recovered from MLN, the bacterial numbers were similar and ranged from 10 to 1,100 bacteria per MLN (data not shown). In the present experiments, which involved 120 rats, E. coli was the only translocating organism recovered from MLN of all except four rats in the control group. From the MLN of these rats, Proteus sp. was recovered from one, coagulase-negative staphylococci were recovered from another, and enterococci were recovered from the other two. Before inoculation with E. coli JK, control rats had what might be considered normal population levels of various groups of intestinal bacteria except that the total numbers of facultative gram-negative bacilli could be considered on the high end of the normal range (1, 6, 8) . Maejima et al. (6) did not recover viable bacteria from the MLN of 20 180-to 210-g control rats. These authors reported cecal coliform quantitation of 103.7 to 105 3/g of cecum, whereas our rats, of similar weights, had cecal coliforms ranging from 106.4 to 1010/g of cecum. Berg (1) observed that translocation of E. coli occurred when cecal populations reached 107 to 108/g, although Berg (1) added that the precise population level required to promote E. coli translocation was not known. The relatively high concentration of cecal coliforms in the present study might have contributed to the high rate of spontaneous translocation of intestinal E. coli observed in these rats. However, it should also be noted that these 200-g rats were only 6 weeks old, and there is some evidence that translocation might be increased in young animals (10, 13). The exact reason for the high rate of spontaneous translocation in these rats is not clear now, but no abnormal gross pathology was noted at autopsy. Indigenous E. coli was recovered from MLN of nearly all (16 [80%] of 20) untreated control rats (Table 1) . These translocating E. coli were uniformly streptomycin sensitive, a fact which is consistent with the observation that indigenous streptomycin-resistant E. coli was not detected in the cecal flora of this rat colony at the time of these experiments. At 48 h after inoculation with 1010 streptomycin-resistant E. coli JK, approximately 105 E. coli JK per g was recovered from the cecal flora, suggesting that control rats had eliminated much of the E. coli JK inoculum. However, E. coli JK was recovered from MLN of three of these rats, possibly reflecting the effect of oral administration of a relatively large number of viable E. coli JK. Other investigators have shown that if the oral inoculum contains sufficient numbers, E. coli will translocate to the MLN in an untreated animal (14, 15) .
Before inoculation with E. coli JK, streptomycin-treated rats had no detectable cecal, streptomycin-resistant, gramnegative bacilli (Table 1 ). This indicated that although streptomycin-resistant E. coli JK had been previously isolated from this rat colony, these animals did not harbor streptomycin-resistant enteric bacilli at the time of the present experiments. Also, as expected, no streptomycin-resistant E. coli was recovered from the MLN of any rat at this time. Interestingly, after 3 days of oral streptomycin therapy (which eliminated all detectable streptomycin-sensitive enteric bacilli), viable streptomycin-sensitive E. coli was recovered from MLN of 9 (45%) of 20 rats even when these bacteria could not be detected in the cecal flora. At 48 h after oral inoculation with E. coli JK, this organism persisted in the cecum in high numbers and translocated to the MLN of 12 (60%) of 20 rats. Surprisingly, 3 of these 20 rats had streptomycin-sensitive E. coli present in MLN not only when these bacteria had been eliminated from the cecal flora for at least 48 h, but also when this segment of the flora had been essentially replaced by E. coli JK.
After 3 days of neomycin therapy, no aerobic or facultative bacteria could be detected in the cecal flora, and the numbers of anaerobic bacteria had increased 100-fold (Table  1) . Streptomycin-sensitive E. coli was recovered from MLN of 9 of 20 rats, repeating the above-mentioned observation that streptomycin-sensitive E. coli was recovered from MLN of nearly one-half of the animals at a time when this organism could not be detected in the cecal flora. In contrast to the observation with streptomycin-treated rats, E. coli JK could not be detected in the cecal flora of neomycin-treated rats after oral inoculation. E. coli is typically sensitive to neomycin, and E. coli JK was most likely killed by neomycin in the intestinal tract. Two rats had viable E. coli JK in MLN, which could be difficult to explain because at this time E. coli JK was not recovered from the cecal flora of these rats. However, this translocation of E. coli JK could have been an inoculum effect; i.e., some translocation could have occurred before the neomycin could effectively eliminate the high nutnbers of E. coli JK in the original oral inoculum. Again, as noted in the streptomycin treatment group, occasional rats (n = 2) had streptomycin-sensitive E. coli in MLN at least 48 h after this organism had been eliminated frbm the cecal flora. Therefore, as with the streptomycin treatment group, occasional neomycin-treated rats had translocating streptomycin-sensitive E. coli that appeared to survive within the MLN for at least 48 h.
As an additional confirmatory experiment, separate groups of 60 rats were orally given streptomycin or neomycin; 12 rats from each group were sacrificed before drug treatment, and then 12 rats per group were sacrificed daily for 4 days. On day 0 (before drug treatment) cecal flora was similar to that of untreated control rats (Table 1) . Subsequent daily cecal cultures showed that after either streptomycin or neomycin therapy, indigenous E. coli was eliminated after 24 h (day 1) and did not return during the four days of the experiment. The recovery of viable, indigenous, streptomycin-sensitive E. coli from the MLN of these streptomycin-and neomycintreated rats is reported in Table 2 . Indigenous E. coli was recovered from MLN during the four days of the experiment. At first inspection, it appears that there is a relatively higher recovery of translocating, indigenous, streptomycinsensitive E. coli reported in Table 2 compared with that  reported in Table 1 . However, in the initial experiment (Table 1) , translocating, streptomycin-resistant E. coli JK was present to compete with translocating, indigenous, streptomycin-sensitive E. coli, with resulting overall translocation rates (or survival rates in MLN) that were not incompatible with those reported in Table 2 . Perhaps in the absence of a break in intestinal mucosal integrity, the translocation rate reflects the availability of a constant finite number of translocating "sites" on the mucosal surface, but support for this speculation is beyond the scope of the present experiments.
The results of this study suggest that translocating E. coli could survive for several days within MLN. This is a curious observation, because MLN consist solely of lymphocytes and macrophages and these macrophages should be quite efficient at phagocytosing and killing translocating E. coli. Although we do not yet know anything about the ability of other organisms to survive within MLN, our observations may help explain why intestinal E. coli has been associated with systemic disease in animal models of bacterial translocation (1, 3, 5, 9, 10, 14, 17) and in human immunosuppressed patients (12, 16, 18) . There are several other reasons why the results of this study may be significant. These results suggest that when experimental protocols designed to eliminate or reduce the rate of bacterial translocation are used, the possibility that the time of bacterial translocation to the MLN might be kinetically different from the time of recovery of viable bacteria from the MLN should be considered. In addition, there is clinical evidence with humans that translocation of intestinal bacteria is responsible for many of the nosocomial bacteremias reported in severely immunosuppressed patients (12, 16, 18) . The results presented here suggest that the MLN may be a focus of infection in these patients. Therefore, when antimicrobial therapy (prophylactic, empiric, or specific) is formulated for these patients, it may be important to consider that the focus of infection may be relatively inaccessible to antimnicrobial agents and to mediators of humoral immunity. 
